DAL vs VRTX · P/E 12, rev $61.64B vs P/E 30, rev $12.00B
Delta Air Lines Inc (DAL) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
DAL currently screens at market cap $52.18B and trailing P/E 11.6. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the DAL and VRTX stock pages for the full models.
Not investment advice.